GemVax & KAEL Co (XKRX:082270) Long-Term Capital Lease Obligation : ₩243 Mil (As of Mar. 2025)

View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Long-Term Capital Lease Obligation?

GemVax & KAEL Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₩243 Mil.

GemVax & KAEL Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (₩179 Mil) to Dec. 2024 (₩122 Mil) but then increased from Dec. 2024 (₩122 Mil) to Mar. 2025 (₩243 Mil).

GemVax & KAEL Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (₩514 Mil) to Dec. 2023 (₩494 Mil) and declined from Dec. 2023 (₩494 Mil) to Dec. 2024 (₩122 Mil).

GemVax & KAEL Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for GemVax & KAEL Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Long-Term Capital Lease Obligation Chart

GemVax & KAEL Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

1,214.99

815.95

514.19

494.29

122.07

GemVax & KAEL Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															254.90	223.12	179.38	122.07	242.73

GemVax & KAEL Co (XKRX:082270) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

GemVax & KAEL Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

GemVax & KAEL Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510

Website

http://www.kael.co.kr

GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines